Sepsis and septic shock: Guideline-based management
暂无分享,去创建一个
[1] Pierre Asfar,et al. Optimizing mean arterial pressure in septic shock: a critical reappraisal of the literature , 2015, Critical Care.
[2] Anand Kumar,et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. , 2009, Chest.
[3] Brian H Cuthbertson,et al. Hydrocortisone therapy for patients with septic shock. , 2008, The New England journal of medicine.
[4] Dellinger Rp. The Surviving Sepsis Campaign: Where have we been and where are we going? , 2015 .
[5] M. Leeflang,et al. Predicting Fluid Responsiveness by Passive Leg Raising: A Systematic Review and Meta-Analysis of 23 Clinical Trials* , 2016, Critical care medicine.
[6] M. Levy,et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive care medicine.
[7] A. Armaganidis,et al. An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients , 2012, Intensive Care Medicine.
[8] M. J. Hall,et al. Inpatient care for septicemia or sepsis: a challenge for patients and hospitals. , 2011, NCHS data brief.
[9] D. Annane,et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial , 2007, The Lancet.
[10] K. Wood,et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock* , 2006, Critical care medicine.
[11] S. Lawless,et al. Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study. , 1996, Chest.
[12] M. Levy,et al. Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour: Results From a Guideline-Based Performance Improvement Program* , 2014, Critical care medicine.
[13] P. Marik,et al. The SEP-1 quality mandate may be harmful: How to drown a patient with 30 mL per kg fluid! , 2017, Anaesthesiology intensive therapy.
[14] J. Sobel,et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] B. Souweine,et al. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock , 2018, The New England journal of medicine.
[16] S. Lemeshow,et al. Time to Treatment and Mortality during Mandated Emergency Care for Sepsis , 2017, The New England journal of medicine.
[17] Peter Schlattmann,et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. , 2013, The Lancet. Infectious diseases.
[18] Richard Beale,et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine , 2014, Intensive Care Medicine.
[19] M. Hameed,et al. Comparison of 8 VS. 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults: A Randomized Trial , 2019 .
[20] C. Sprung,et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012 , 2013, Intensive Care Medicine.
[21] C. Schermer,et al. Meta-analysis of high- versus low-chloride content in perioperative and critical care fluid resuscitation , 2014, The British journal of surgery.
[22] S. Jaber,et al. Evaluation of pulse pressure variation validity criteria in critically ill patients: a prospective observational multicentre point-prevalence study. , 2014, British journal of anaesthesia.
[23] Sangeeta Mehta,et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 , 2017, Intensive Care Medicine.
[24] R. Cavallazzi,et al. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: A systematic review of the literature* , 2009, Critical care medicine.
[25] R. Dellinger. The Surviving Sepsis Campaign: Where have we been and where are we going? , 2015, Cleveland Clinic Journal of Medicine.
[26] P. Marik,et al. Passive leg raising for predicting fluid responsiveness: a systematic review and meta-analysis , 2016, Intensive Care Medicine.
[27] M. Taljaard,et al. Prognostic Accuracy of the Quick Sequential Organ Failure Assessment for Mortality in Patients With Suspected Infection , 2018, Annals of Internal Medicine.
[28] R. Bellomo,et al. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock , 2018, The New England journal of medicine.
[29] G. Guyatt,et al. Corticosteroids in Sepsis: An Updated Systematic Review and Meta-Analysis , 2018, Critical care medicine.
[30] Véronique Sébille,et al. Effect of Treatment With Low Doses of Hydrocortisone and Fludrocortisone on Mortality in Patients With Septic Shock , 2002 .
[31] Fethi Gül,et al. Changing Definitions of Sepsis. , 2017, Turkish journal of anaesthesiology and reanimation.
[32] Adil Rafiq Rather,et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) , 2015 .
[33] G. Clermont,et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.
[34] Mitchell M. Levy,et al. Lactate Measurements in Sepsis-Induced Tissue Hypoperfusion: Results From the Surviving Sepsis Campaign Database* , 2015, Critical care medicine.
[35] E. Lang,et al. Vasopressors for hypotensive shock. , 2013, Annals of emergency medicine.
[36] R. Bone. Guidelines for the Use of Innovative Therapies in Sepsis , 1993 .
[37] Jesse M. Ehrenfeld,et al. Balanced Crystalloids versus Saline in Critically Ill Adults , 2018, Journal Club AINS.
[38] Sylvie Chevret,et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. , 2013, JAMA.
[39] H. Ammar,et al. Angiotensin II for the Treatment of Vasodilatory Shock. , 2017, The New England journal of medicine.
[40] R. Bellomo,et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.
[41] W. Burdick. A comparison of albumin and saline for fluid resuscitation in the Intensive Care unit , 2005 .
[42] J. Greenslade,et al. Systemic Inflammatory Response Syndrome, Quick Sequential Organ Function Assessment, and Organ Dysfunction: Insights From a Prospective Database of ED Patients With Infection , 2017, Chest.
[43] Matthew M Churpek,et al. Identifying Patients With Sepsis on the Hospital Wards , 2017, Chest.
[44] W. Knaus,et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.
[45] T. Rea,et al. Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.
[46] L. Gattinoni,et al. The clinical use of albumin: the point of view of a specialist in intensive care. , 2009, Blood transfusion = Trasfusione del sangue.
[47] Sangeeta Mehta,et al. Vasopressin versus norepinephrine infusion in patients with septic shock. , 2008, The New England journal of medicine.
[48] Michael Bailey,et al. Early, Goal‐Directed Therapy for Septic Shock — A Patient‐Level Meta‐Analysis , 2017, The New England journal of medicine.
[49] J. Bakker,et al. Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial , 2019, JAMA.
[50] P. Marik,et al. Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. , 2014, Anaesthesiology intensive therapy.
[51] H. Gershengorn,et al. Association Between US Norepinephrine Shortage and Mortality Among Patients With Septic Shock , 2017, JAMA.
[52] Stephen D. Persell,et al. Prompting physicians to address a daily checklist and process of care and clinical outcomes: a single-site study. , 2011, American journal of respiratory and critical care medicine.
[53] E. Ivers,et al. Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock , 2001 .
[54] C. Sandoval. Short-Course Versus Prolonged-Course Antibiotic Therapy for Hospital-Acquired Pneumonia in Critically Ill Adults. , 2016, Critical care nurse.
[55] Michael Bailey,et al. Goal-directed resuscitation for patients with early septic shock. , 2014, The New England journal of medicine.
[56] C. Solano,et al. Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[57] J. Garnacho-Montero,et al. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock , 2013, Intensive Care Medicine.
[58] Leonard Leibovici,et al. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis , 2015, PloS one.
[59] Alan E. Jones,et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. , 2010, JAMA.
[60] S. Townsend,et al. Evidence Underpinning the Centers for Medicare & Medicaid Services' Severe Sepsis and Septic Shock Management Bundle (SEP-1) , 2018, Annals of Internal Medicine.
[61] Barrett T. Kitch,et al. Compliance With the National SEP-1 Quality Measure and Association With Sepsis Outcomes: A Multicenter Retrospective Cohort Study* , 2018, Critical care medicine.
[62] J. Vincent,et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.
[63] J. Marshall,et al. Source control in the management of sepsis , 2001, Intensive Care Medicine.
[64] J. Vincent,et al. Comparison of dopamine and norepinephrine in the treatment of shock. , 2010, The New England journal of medicine.
[65] Claude Guerin,et al. High versus low blood-pressure target in patients with septic shock. , 2014, The New England journal of medicine.
[66] Michel Wolff,et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. , 2003, JAMA.
[67] R. Bellomo,et al. Effect of a Buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit: The SPLIT Randomized Clinical Trial. , 2015, JAMA.
[68] Amber E Barnato,et al. A randomized trial of protocol-based care for early septic shock. , 2014, The New England journal of medicine.
[69] Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock , 2003, Current infectious disease reports.
[70] R. Fowler,et al. Systematic Review and Meta-Analysis of Procalcitonin-Guidance Versus Usual Care for Antimicrobial Management in Critically Ill Patients: Focus on Subgroups Based on Antibiotic Initiation, Cessation, or Mixed Strategies* , 2018, Critical care medicine.
[71] J. Tenhunen,et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. , 2012, The New England journal of medicine.
[72] Joshua A. Doherty,et al. Empiric Combination Antibiotic Therapy Is Associated with Improved Outcome against Sepsis Due to Gram-Negative Bacteria: a Retrospective Analysis , 2010, Antimicrobial Agents and Chemotherapy.
[73] Michael Baram,et al. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. , 2008, Chest.
[74] M. Vollmer,et al. Quality Improvement Initiative for Severe Sepsis and Septic Shock Reduces 90-Day Mortality: A 7.5-Year Observational Study* , 2017, Critical care medicine.
[75] S. Lemeshow,et al. Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study , 2014, Intensive Care Medicine.
[76] J. Bakker,et al. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. , 2010, American journal of respiratory and critical care medicine.
[77] B. Levy,et al. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study* , 2011, Critical care medicine.
[78] Robyn Norton,et al. A comparison of albumin and saline for fluid resuscitation in the Intensive Care unit , 2005 .
[79] Mitchell M. Levy,et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.
[80] J. Briegel,et al. Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial. , 2016, JAMA.
[81] D. Mannino,et al. The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.
[82] D. Annane,et al. Corticosteroids for treating sepsis. , 2015, The Cochrane database of systematic reviews.
[83] Chao Qi,et al. Rapid Detection of Methicillin‐Resistant Staphylococcus aureus in BAL: A Pilot Randomized Controlled Trial , 2019, Chest.
[84] G. Perkins,et al. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial. , 2016, JAMA.
[85] Tom Dormans,et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. , 2016, The Lancet. Infectious diseases.
[86] E. Mylonakis,et al. The Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening to Rule Out MRSA Pneumonia: A Diagnostic Meta-analysis With Antimicrobial Stewardship Implications , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[87] Thomas W. L. Scheeren,et al. Current use of vasopressors in septic shock , 2019, Annals of Intensive Care.
[88] G. Van den Berghe,et al. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017 , 2018, Intensive Care Medicine.
[89] Mao Zhang,et al. Albumin versus Other Fluids for Fluid Resuscitation in Patients with Sepsis: A Meta-Analysis , 2014, PloS one.
[90] M. Mathru. Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock , 2010 .
[91] J. Rello,et al. Sepsis: A Review of Advances in Management , 2017, Advances in Therapy.
[92] J. Vincent,et al. Dopamine versus norepinephrine in the treatment of septic shock: A meta-analysis* , 2012, Critical care medicine.
[93] Derek Bell,et al. Trial of early, goal-directed resuscitation for septic shock. , 2015, The New England journal of medicine.
[94] S. Lemeshow,et al. Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. , 2015, Critical care medicine.
[95] Mervyn Singer,et al. Biomarkers in sepsis , 2013, Current Opinion in Pulmonary Medicine.
[96] Jian-feng Xie,et al. Effect of levosimendan on mortality in severe sepsis and septic shock: a meta-analysis of randomised trials , 2018, BMJ Open.
[97] Anand Kumar,et al. Incorporating Dynamic Assessment of Fluid Responsiveness Into Goal-Directed Therapy: A Systematic Review and Meta-Analysis , 2017, Critical care medicine.
[98] C. Rhee,et al. The CMS Sepsis Mandate: Right Disease, Wrong Measure , 2016, Annals of Internal Medicine.
[99] C. Sprung,et al. The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock , 2009, Intensive Care Medicine.